PHARMACOKINETICS OF SUBCUTANEOUS INFLIXIMAB INDUCTION AND MAINTENANCE IN MODERATE-TO-SEVERELY ACTIVE CROHN'S DISEASE PATIENTS: WEIGHT MATTERS

被引：0
|
作者：
Anjie, Suzanne I.
Mathot, Ron
Gecse, Krisztina
D'Haens, Geert
机构：
来源：
GASTROENTEROLOGY | 2024年 / 166卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Su1811
引用
收藏
页码：S824 / S825
页数：2
相关论文
共 50 条
  • [1] Pharmacokinetics of subcutaneous infliximab induction and maintenance in patients with moderate-to-severely active Crohn's disease
    Anjie, S.
    Mathot, R. A. A.
    Gecse, K. B.
    D'Haens, G. R. A. M.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I1422 - I1422
  • [2] The Safety and Efficacy of Induction and Maintenance Therapy with Infliximab in Children with Severely Active Crohn's Disease
    Kierkus, Jaroslaw
    Dadalski, Maciej
    Ryzko, Jozef
    Socha, Piotr
    Oracz, Grzegorz
    Szczepanski, Michal
    Szymanska, Edyta
    Socha, Jerzy
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2009, 104 : S469 - S469
  • [3] Maintenance therapy with subcutaneous infliximab for Crohn's disease
    Gomersall, Bethany
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2023, 8 (07): : 608 - 608
  • [4] Induction and maintenance infliximab therapy for the treatment of moderate-to-severe Crohn's disease in children
    Hyams, Jeffrey
    Crandall, Wallace
    Kugathasan, Subra
    Griffiths, Anne
    Olson, Allan
    Johanns, Jewel
    Liu, Grace
    Travers, Suzanne
    Heuschkel, Robert
    Markowitz, James
    Cohen, Stanley
    Winter, Harland
    Veereman-Wauters, Gigi
    Ferry, George
    Baldassano, Robert
    GASTROENTEROLOGY, 2007, 132 (03) : 863 - 873
  • [5] Pharmacokinetics of Laquinimod in Patients With Active Moderate to Severe Crohn's Disease
    D'Haens, Geert R.
    Sandborn, William
    Colombel, Jean-Frederic
    Mimrod, Dorit
    Spiegelstein, Ofer
    Brown, Kurt
    Feagan, Brian G.
    GASTROENTEROLOGY, 2014, 146 (05) : S368 - S368
  • [6] Pharmacokinetics of laquinimod in patients with active moderate to severe Crohn's disease
    D'Haens, G.
    Sandborn, W. J.
    Rutgeerts, P.
    Colombel, J. F.
    Mimrod, D.
    Spiegelstein, O.
    Brown, K.
    Feagan, B.
    JOURNAL OF CROHNS & COLITIS, 2014, 8 : S226 - S226
  • [7] Infliximab as an induction agent versus ongoing maintenance therapy in mild-moderate pediatric Crohn's disease
    Feldman, Tamara L.
    Youssef, Nader N.
    Ruth, Irizarry
    Rosh, Joel R.
    GASTROENTEROLOGY, 2007, 132 (04) : A444 - A444
  • [8] Consistency of treatment benefit with infliximab in patients with moderate-to-severe active Crohn's disease
    Vasiliauskas, E
    Targan, S
    Sands, B
    Hanauer, S
    Mayer, L
    Present, D
    Braakman, T
    DeWoody, K
    Schaible, T
    Rutgeerts, P
    GASTROENTEROLOGY, 1999, 116 (04) : A837 - A837
  • [9] Cost Utility of Adalimumab versus Infliximab Maintenance Therapies in the United States for Moderately to Severely Active Crohn’s Disease
    Andrew P. Yu
    Scott Johnson
    Si-Tien Wang
    Pavel Atanasov
    Jackson Tang
    Eric Wu
    Jingdong Chao
    Parvez M. Mulani
    PharmacoEconomics, 2009, 27 : 609 - 621
  • [10] Cost Utility of Adalimumab versus Infliximab Maintenance Therapies in the United States for Moderately to Severely Active Crohn's Disease
    Yu, Andrew P.
    Johnson, Scott
    Wang, Si-Tien
    Atanasov, Pavel
    Tang, Jackson
    Wu, Eric
    Chao, Jingdong
    Mulani, Parvez M.
    PHARMACOECONOMICS, 2009, 27 (07) : 609 - 621
12345